86 related articles for article (PubMed ID: 27847369)
1. Trained Immunity and Susceptibility to HIV.
Derrick SC
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847369
[TBL] [Abstract][Full Text] [Related]
2. Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.
Jensen K; Dela Pena-Ponce MG; Piatak M; Shoemaker R; Oswald K; Jacobs WR; Fennelly G; Lucero C; Mollan KR; Hudgens MG; Amedee A; Kozlowski PA; Estes JD; Lifson JD; Van Rompay KK; Larsen M; De Paris K
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27655885
[TBL] [Abstract][Full Text] [Related]
3. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
[TBL] [Abstract][Full Text] [Related]
4. Immunity in natural SIV infections.
Silvestri G
J Intern Med; 2009 Jan; 265(1):97-109. PubMed ID: 19093963
[TBL] [Abstract][Full Text] [Related]
5. Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection.
Shen Y; Zhou D; Chalifoux L; Shen L; Simon M; Zeng X; Lai X; Li Y; Sehgal P; Letvin NL; Chen ZW
Infect Immun; 2002 Feb; 70(2):869-77. PubMed ID: 11796622
[TBL] [Abstract][Full Text] [Related]
6. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.
Staprans SI; Barry AP; Silvestri G; Safrit JT; Kozyr N; Sumpter B; Nguyen H; McClure H; Montefiori D; Cohen JI; Feinberg MB
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13026-31. PubMed ID: 15326293
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic dendritic-cell vaccine for simian AIDS.
Lu W; Wu X; Lu Y; Guo W; Andrieu JM
Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
[TBL] [Abstract][Full Text] [Related]
10. Induction of CD8+ regulatory T cells protects macaques against SIV challenge.
Lu W; Chen S; Lai C; Guo W; Fu L; Andrieu JM
Cell Rep; 2012 Dec; 2(6):1736-46. PubMed ID: 23260669
[TBL] [Abstract][Full Text] [Related]
11. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
13. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
[TBL] [Abstract][Full Text] [Related]
14. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
[TBL] [Abstract][Full Text] [Related]
15. Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
Wood MP; Wood LF; Templeton M; Fisher B; Lippy A; Jones CI; Lindestam Arlehamn CS; Sette A; Fuller JT; Murapa P; Jaspan HB; Fuller DH; Sodora DL
J Infect Dis; 2020 Jun; 222(1):44-53. PubMed ID: 31605528
[TBL] [Abstract][Full Text] [Related]
16. A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.
Jensen K; Ranganathan UD; Van Rompay KK; Canfield DR; Khan I; Ravindran R; Luciw PA; Jacobs WR; Fennelly G; Larsen MH; Abel K
Clin Vaccine Immunol; 2012 Aug; 19(8):1170-81. PubMed ID: 22695156
[TBL] [Abstract][Full Text] [Related]
17. Epithelium-innate immune cell axis in mucosal responses to SIV.
Shang L; Duan L; Perkey KE; Wietgrefe S; Zupancic M; Smith AJ; Southern PJ; Johnson RP; Haase AT
Mucosal Immunol; 2017 Mar; 10(2):508-519. PubMed ID: 27435105
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
19. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
20. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
